The 2026 FDA Update What Happened Before In 2023 and 2024, the FDA told pharmacies to stop making BPC157 and TB500 because there was not enough safety data
Use Sterile Equipment: A lways use new, sterile syringes, needles, alcohol swabs, and vials for each injection
In the UK, NICE guidance (TA875) recommends Wegovy for adults with a BMI of at least 35 kg/m (or 30 kg/m with weight-related comorbidities), with lower thresholds for some ethnic groups
The FDAs Pharmacy Compounding Advisory Committee (PCAC) met Thursday and Friday to review some of the controversial, popular peptide injections and discuss whether compounding pharmacies should be able to dispense them
Read that background separately from this news update: the regulatory status described here is tied to the July 23 committee result and can change again when FDA acts
I will read again and mull over and I will find the link and post the article my daughter read